Across TCGA pan-cancer cohorts, SNORD114-1 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of SNORD114-1’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where SNORD114-1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORD114-1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.
LUAD and KICH are the cancer types where SNORD114-1 tumor–normal differential expression is most reproducible.